Altria Group (MO)
(Delayed Data from NYSE)
$53.36 USD
+0.14 (0.26%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $53.35 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$53.36 USD
+0.14 (0.26%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $53.35 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $48.74 in the latest trading session, marking a +0.58% move from the prior day.
The Zacks Analyst Blog Highlights: United Parcel Service, ServiceNow, CVS Health, Booking Holdings and Altria Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: United Parcel Service, ServiceNow, CVS Health, Booking Holdings and Altria Group
Top Stock Reports for United Parcel Service, ServiceNow & CVS Health
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including United Parcel Service, Inc. (UPS), ServiceNow, Inc. (NOW), and CVS Health Corporation (CVS).
Altria (MO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $48.03 in the latest trading session, marking a -0.23% move from the prior day.
Philip Morris (PM) Strives to Expand IQOS & Beyond Nicotine
by Zacks Equity Research
Philip Morris (PM) is gaining from growing consumer acceptance for IQOS devices. It is on track with the expansion of Beyond Nicotine products to support inhaled therapeutics.
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $49.23, moving +1.78% from the previous trading session.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $50.88 in the latest trading session, marking a +0.18% move from the prior day.
Altria (MO) Benefits From Low-Risk Products, High Pricing
by Zacks Equity Research
Altria (MO) is gaining from rising popularity of IQOS and on!. Strong pricing for tobacco products is also driving revenue growth.
Philip Morris (PM) Gains on IQOS, Beyond Nicotine Expansion
by Zacks Equity Research
Philip Morris (PM) is gaining from rising popularity of IQOS devices. The company is also progressing with the expansion of Beyond Nicotine products that cater to medical wellness.
Altria (MO) Hikes Dividend, Boosts Shareholders' Wealth
by Zacks Equity Research
Altria (MO) raises quarterly dividend by 4.7% to 90 cents per share. The company's new annualized dividend rate is $3.60 per share.
Philip Morris (PM) Fuels Smoke-Free Offerings With IQOS ILUMA
by Zacks Equity Research
Philip Morris International (PM) unveils the launch of IQOS ILUMA. These bladeless devices generate no smoke and combustion, and will strengthen the company's smoke-free portfolio.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Top Research Reports for Costco, Altria & Edwards Lifesciences
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale (COST), Altria Group, Inc. (MO), and Edwards Lifesciences (EW).
Company News for Jul 30, 2021
by Zacks Equity Research
Companies In The News Are: NOK, YUM, MA, MO.
Altria (MO) Q2 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Altria's (MO) second-quarter performance reflects gains from growth in revenues across all categories, backed by favorable pricing variance and shipment volumes.
Altria (MO) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of 5.13% and 4.71%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Altria (MO) Lined Up for Q2 Earnings: Key Things to Note
by Zacks Equity Research
Altria's (MO) second-quarter 2021 results are likely to reflect solid pricing power and strength in oral tobacco products.
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $47.49, moving +1.06% from the previous trading session.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $46.99, marking a -0.72% move from the previous day.
Altria (MO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Altria (MO) Stock Moves -0.46%: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $47.27, moving -0.46% from the previous trading session.
Altria (MO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $47.49, moving +0.19% from the previous trading session.
Altria (MO) to Divest Ste. Michelle Wine Estates Business
by Zacks Equity Research
Altria's (MO) subsidiary agrees to sell Ste. Michelle Wine Estates business. The move will boost shareholders' value, while aiding in smooth transition of adult smokers to a non-combustible future.
Company News for Jul 12, 2021
by Zacks Equity Research
Companies In The News Are: LEVI, PM, UAL, MO
Altria (MO) Up 14% in 6 Months, Gains on Low-Risk Products
by Zacks Equity Research
Altria's (MO) low-risk tobacco offerings such as IQOS and on! are gaining popularity. Moreover, strong pricing for tobacco products is an upside.